Dupilumab - Regeneron/Sanofi
At a glance
- Drug Originator Regeneron Pharmaceuticals; sanofi-aventis
- Drug Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antifungals; Antineoplastics; Antipruritics; Immunotherapies; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin 13 receptor antagonists; Interleukin 4 receptor antagonists
- USA Patent Applicants REGENERON PHARMACEUTICALS
- USA Patents 36
- BLAs 1
- International Patents 508
Disclaimer